Skip to content

CRE Reference 24-well

by AusDiagnostics Pty Ltd 2 variants

Ref 81099P

CRE Reference 24-well (81099P) is an in vitro diagnostic device (EU IVDD general IVD) made by AusDiagnostics Pty Ltd, registered in EUDAMED on 24 Oct 2023 (Basic UDI-DI B-09343044004735), active as of 25 Oct 2026.

Active European Union

CE IVDD

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not applicable

No FDA record for this device

Documents

None, self-declared

Class I: no certifier involved

Trust

Unverified

Source EUDAMED, synced 25 Oct 2026.

Regulatory status

as of registry sync 25 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD NumberB-09343044004735 Basic UDI-DI 09343044004735UDI-DIDate24 Oct 2023RegisteredStatusActive

Official records

Certificates

0 certificates · EUDAMED

No certifier certificate is listed. Devices of this class are self-declared by the manufacturer.

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/IVDD Active

Specification

EUDAMED

Device name
Step 2 Plates for CRE Reference 24-well
Model / reference
81099P
Primary DI / UDI-DI
09343044004735
Basic UDI-DI
B-09343044004735
EMDN code
W0104080605, W0104080606
Device class
Class IVD General
EU registration type
Legacy device (under a directive)
EU market of registration
Malta

Manufacturer details

EUDAMED SRN
AU-MF-000020558
Authorised representative
Advena Limited MT-AR-000000234

Similar devices in this category

Other devices filed under NUCLEIC ACID IDENTIFICATION (BACTERIOLOGY).

Other devices from AusDiagnostics Pty Ltd

See all devices from AusDiagnostics Pty Ltd →

Properties

  • Reagent
  • Professional testing
Other properties (10, all answered No)